ArticleScience advances2025

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastoma.

Jeremy Z R Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.